Drug Type Cytokines |
Synonyms- |
Target |
Mechanism IFNGR1 modulators(interferon gamma receptor 1 modulators), TNFR1 modulators(Tumor necrosis factor receptor superfamily member 1A modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | 26 Oct 2024 |